Key Developments: ICU Medical Inc (ICUI.O)
68.25USD
2:57pm EDT
$-0.29 (-0.42%)
$68.54
$68.74
$69.50
$68.20
49,147
99,443
$71.29
$49.72
Latest Key Developments (Source: Significant Developments)
ICU Medical Inc Reaffirms FY 2013 EPS Guidance; Lowers High End Of Prior FY 2013 Revenue Guidance To A Range In Line With Analysts' Estimates
ICU Medical Inc announced that due to current business trends in certain market segments, the Company is lowering the upper end of its previously issued revenue guidance. For fiscal 2013, it expects to generate revenue in the range of $330-$337 million, compared to the previous guidance of $330-$340 million. The Company is reiterating its previous guidance of diluted earnings in the range of $2.70 to $2.85 per share. According to I/B/E/S Estimates, analysts on an average were expecting the Company to report revenue of $335 million and EPS of $2.77 for fiscal 2013. Full Article
ICU Medical Inc Issues FY 2013 Guidance; EPS GuidanceBelow Analysts' Estimates
ICU Medical Inc announced that for fiscal 2013, it expects to generate revenue in the range of $330 million to $340 million and diluted earnings in the range of $2.70 to $2.85 per share (EPS). According to I/B/E/S Estimates, analysts on an average were expecting the Company to report revenue of $339 million and EPS of $2.89 for fiscal 2013. Full Article
ICU Medical Inc Lowers FY 2012 Revenue Guidance; Raises FY 2012 EPS Guidance
ICU Medical Inc announced that for fiscal 2012, it is lowering its previously announced revenue guidance range. The new range is $315 million to $318 million, compared to the previous range of $318 million to $325 million. Management is raising its previously announced diluted earnings guidance range. The new range is $2.75 to $2.80 per share, compared to the previous range of $2.55 to $2.70 per share. According to I/B/E/S Estimates, analysts are expecting the Company to report revenue of $320 million and EPS of $2.60 for fiscal 2012. Full Article
ICU Medical Inc Raises Low End Of Prior FY 2012 EPS Guidance; Lowers High End Of Prior FY 2012 Revenue Guidance
ICU Medical Inc announced that based on the current business trends, the Company is narrowing previously announced revenue guidance range for fiscal 2012. The new range is $318 million to $325 million, compared to the previous range of $318 million to $330 million. The Company is also raising the bottom end of previously announced diluted earnings guidance range for fiscal 2012. The new range is $2.55 to $2.70 per share, compared to the previous range of $2.45 to $2.70 per share. Full Article
ICU Medical Inc Signs Agreement with ROi
ICU Medical Inc announced that it has signed a contract with ROi (Resource Optimization & Innovation) for MicroClave Clear neutral displacement needlefree IV connectors to be used on central and peripheral IV lines at Mercy. Full Article
ICU Medical, Inc. Reaffirms FY 2012 Guidance
ICU Medical, Inc. announced that it reaffirms revenue guidance for fiscal 2012 and expects to generate revenue in the range of $318-$330 million, diluted earnings (EPS) in the range of $2.45-$2.70 per share. According to I/B/E/S Estimates, analysts are expecting the Company to report revenue of $322 million and EPS of $2.56 for fiscal 2012. Full Article
ICU Medical, Inc. Announces Filing of Form 12b-25 for 15 Calendar Day Extension to File Its 2011 Annual Report on Form 10-K
ICU Medical, Inc. announced that it anticipates filing a Form 12b-25, Notification of Late Filing, with the Securities and Exchange Commission with respect to its Form 10-K, which allows the Company an additional 15 calendar days to file the Form 10-K which is otherwise due on March 14, 2012. The delay in filing has been caused by an analysis of certain accounting items related to an under estimation in the rebate reserves that amounted to an increase to the reserves and a reduction to net sales and operating income of approximately $2.5 million for the year ended December 31, 2009. For the year ended December 31, 2010 the Company made an additional reserve adjustment and a reduction of revenues and operating income of approximately $1.6 million. Full Article
ICU Medical, Inc. Issues FY 2012 Guidance Below Analysts' Estimates
ICU Medical, Inc. announced that for fiscal 2012, it expects to generate revenue in the range of $318 million to $330 million, diluted earnings in the range of $2.45 to $2.70 per share. According to I/B/E/S Estimates, analysts on an average are expecting the Company to report revenue of $339 million and EPS of $2.95 for fiscal 2012. Full Article
ICU Medical, Inc. Secures Contract
ICU Medical, Inc. announced it has been awarded a 36 month contract with Novation for its full line of Critical Care products, including hemodynamic monitors and catheters, disposable pressure transducers, and in-line blood sampling systems. Effective January 1, 2012, the new agreement allows the members served by Novation to take advantage of special pricing and terms pre-negotiated by Novation. Full Article
ICU Medical, Inc. Raises Low End Of Prior FY 2011 Revenue Guidance To A Range In Line With Analysts' Estimates; Raises Prior FY 2011 EPS Guidance
ICU Medical, Inc. announced that for fiscal 2011, it is raising the bottom end of its previously announced revenue guidance range. The new range is $300-$305 million, compared to its previous range of $297-$305 million. The Company also raising its earnings per share (EPS) guidance range. The new range is $2.43-$2.54 per share, compared to its previous range of $2.35 to $2.50 per share. According to I/B/E/S Estimates, analysts are expecting the Company to report revenues of $305 million and EPS of $2.46 for fiscal 2011. Full Article
ICU Medical explores possible $1 billion sale: Bloomberg
NEW YORK - San Clemente, California-based medical device provider ICU Medical Inc is considering a sale that could fetch more than $1 billion, according to a Bloomberg News report Wednesday morning.
Earnings vs. 
Estimates
Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.
NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
